STOCKSBiogen May Shed $18 Billion in Value After Scrapping Alzheimer's Drug TrialBy Martin BaccardaxMar 21, 2019 1:04 PM EDT
MARKETSDow Tumbles as Rally Spurred by Trade Deal Hopes FadesBy Joseph WoelfelMar 4, 2019 4:17 PM EST
INVESTINGNightstar Soars as Biogen to Buy Gene Therapy Company for $877 MillionBy Tony OwusuMar 4, 2019 9:33 AM EST
INVESTINGGrowth Stocks, Market Movers, Google's China ChallengeBy Gregg GreenbergJan 13, 2010 4:47 PM EST
JIM CRAMERCramer's 'Mad Money' Recap: Next Week's Game Plan (Final)By Scott RuttNov 20, 2009 6:43 PM EST
JIM CRAMERCramer's 'Mad Money' Recap: The Bernanke Bounce (Final)By Scott RuttNov 16, 2009 6:39 PM EST
